University of Queensland researchers are designing nanotechnology they believe could improve how we treat the most aggre...
South Korea-based LigaChem Biosciences has announced a $25 million strategic investment in its partner, Iksuda Therapeut...
Image Caption: Deputy Prime Minister Mr Heng Swee Keat with Professor Ashok Venkitaraman, ...
Shimadzu Scientific Korea Corporation (SSK), a subsidiary of Japan-headquartered firm Shimadzu in South Korea, and Chung...
British pharmaceutical company AstraZeneca has announced an investment of $2.5 billion in Beijing to establish its sixth...
In a strategic move for medical research and innovation, Duke NUS Medical School and the National University of Singapor...
The Prime Minister of New Zealand, Christopher Luxon, recently chaired an education focused event at the Indian Institut...
The Hong Kong Polytechnic University (PolyU) has submitted a proposal to the Hong Kong Special Administrative Region (HK...
Japan-based Taiho Pharmaceutical and Araris Biotech AG, a Swiss biotechnology company developing next-generation antibod...
Japan-based Murata Manufacturing Co. has successfully commercialised and mass produced "CELLNETTA," the world’s fi...
Showcasing Innovation Through Specialized Pavilions BIX 2025 will spotlight four specialized pavilions, each dedicated ...
China & US based Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and...
Nanyang Technological University (NTU) in Singapore and VinUniversity in Vietnam have signed a Memorandum of Understandi...
ENCell Co., Ltd., a South Korean biotech company specialising in advanced biopharmaceutical contract development and man...
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has successfu...
Elsevier, a global leader in advanced information and decision support, launches ScienceDirect AI, a cutting-edge g...
US-based Nosis Biosciences, an AI-driven biotechnology company specialising in RNA therapeutics for challenging cell typ...
The year 2025 is set to be a pivotal year for the health, bioscience, and biopharma sectors, as emerging trends shape he...
